Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
27.71
-0.03 (-0.11%)
At close: Apr 6, 2026, 4:00 PM EDT
27.80
+0.09 (0.32%)
After-hours: Apr 6, 2026, 7:41 PM EDT
HRMY Market Cap
HRMY has a market cap or net worth of $1.6 billion as of April 6, 2026. Its market cap has decreased by -19.88% in one year.
Market Cap
1.60B
Enterprise Value
997.41M
1-Year Change
-19.88%
Ranking
Category
Stock Price
$27.71
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $1.60B, an increase of 247.81%. That is a compound annual growth rate of 24.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 1.60B | -25.60% |
| Dec 31, 2025 | 2.16B | 9.82% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnaptysBio | 1.66B |
| Recursion Pharmaceuticals | 1.64B |
| Rapport Therapeutics | 1.61B |
| Nurix Therapeutics | 1.60B |
| Oculis Holding AG | 1.58B |
| MBX Biosciences | 1.57B |
| Immunocore Holdings | 1.56B |
| Intellia Therapeutics | 1.55B |